A detailed history of Private Capital Group, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 26 shares of ARVN stock, worth $491. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26
Holding current value
$491
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

BUY
$36.01 - $74.24 $936 - $1,930
26 New
26 $1,000
Q1 2022

Apr 21, 2022

SELL
$60.27 - $81.57 $1,024 - $1,386
-17 Closed
0 $0
Q3 2021

Oct 13, 2021

SELL
$73.2 - $107.87 $146 - $215
-2 Reduced 10.53%
17 $1,000
Q2 2021

Jul 26, 2021

BUY
$60.45 - $84.26 $1,148 - $1,600
19 New
19 $2,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.01B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.